Products for Research Use Only
RegisterLogin

Aclacinomycin A (hydrochloride)

CAT: 0804-HY-N2306ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N2306ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Aclacinomycin A (Aclarubicin) hydrochloride is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A hydrochloride is an inhibitor of topoisomerase I and II. Aclacinomycin A hydrochloride inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A hydrochloride might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis[1][2][3].
CAS Number
75443-99-1
Product Name Alternative
Aclarubicin (hydrochloride)
UNSPSC
12352005
Hazard Statement
H301-H311-H331
Target
Antibiotic; DNA/RNA Synthesis; Proteasome; Topoisomerase
Type
Natural Products
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Aclacinomycin_A_hydrochloride.html
Purity
95.16
Solubility
10 mM in H2O|DMSO : ≥ 125 mg/mL
Smiles
O=C([C@@H]1C2=CC(C(C3=CC=CC(O)=C43)=O)=C(C4=O)C(O)=C2[C@@H](O[C@@](O[C@@H](C)[C@H]5O[C@@](O[C@@H](C)[C@H]6O[C@](CCC7=O)([H])O[C@H]7C)([H])C[C@@H]6O)([H])C[C@@H]5N(C)C)C[C@]1(O)CC)OC.Cl
Molecular Formula
C42H54ClNO15
Molecular Weight
848.33
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361+P364-P403+P233-P405-P501
References & Citations
[1]Isoe T, et al. Inhibition of different steps of the ubiquitin system by CDDP and aclarubicin. Biochim Biophys Acta. 1992 Sep 15;1117 (2) :131-5.|[2]Hajji N, et al. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor. Mutat Res. 2005 May 2;583 (1) :26-35.|[3]Iihoshi H, et al. Aclarubicin, an anthracycline anti-cancer drug, fluorescently contrasts mitochondria and reduces the oxygen consumption rate in living human cells. Toxicol Lett. 2017 Aug 5;277:109-114.|[4]Hori S, et al. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity. Gan. 1977 Oct;68 (5) :685-90.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
Launched
Isoform
Topo I; Topo II
Citation 01
Bioengineered. 2022 Feb;13 (2) :2207-2216.|bioRxiv. 2023 Jan 13.|Int J Hyperthermia. 2022;39 (1) :998-1009.|Biomolecules. 2025 Jul 6.|Patent. US20250129329A1.

Related Products

CatalogName
HY-N2306-01Aclacinomycin A
HY-N2306RAclacinomycin A (Standard)
HY-B0500BAlverine (hydrochloride)
HY-W714513VU0469650 (hydrochloride)
HY-W708286-01α-Pyrrolidinobutiothiophenone (hydrochloride)
HY-W492795Quifenadine (hydrochloride)
HY-W012179-01Phenylpiperazine (hydrochloride)
HY-Z6449-01Phenylephrone (hydrochloride)
HY-W209279(±) Anabasine (hydrochloride)
HY-W027446-01Pyridoxal hydrochloride

Alternative Products

CatalogName
C04659Aclacinomycin A hydrochloride
BUP21866Aclacinomycin A
MBS5773382Aclacinomycin
A14910-10Aclacinomycin A 10mg
257194-01Aclacinomycin HCl
440910-01Aclarubicin (Aclacinomycin A)
abx283139-01Aclacinomycin A HCl
A14910-5Aclacinomycin A 5mg
A14910-1Aclacinomycin A 1mg

Popular Products